vs
ACI WORLDWIDE, INC.（ACIW）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
ACI WORLDWIDE, INC.的季度营收约是Orthofix Medical Inc.的1.9倍（$425.7M vs $219.9M），ACI WORLDWIDE, INC.净利率更高（9.0% vs -1.0%，领先10.0%），ACI WORLDWIDE, INC.同比增速更快（7.9% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 6.8%）
ACI Worldwide是全球领先的数字支付软件企业，总部位于美国内布拉斯加州埃尔克霍恩，为94个国家的客户提供服务，每日处理数十亿笔交易，总价值达数万亿美元。其智能解决方案服务于银行、金融机构、商户、账单服务商、收单机构、发卡机构及第三方支付服务商，支持全渠道搭建安全支付体系。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ACIW vs OFIX — 直观对比
营收规模更大
ACIW
是对方的1.9倍
$219.9M
营收增速更快
ACIW
高出5.9%
2.0%
净利率更高
ACIW
高出10.0%
-1.0%
两年增速更快
OFIX
近两年复合增速
6.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $425.7M | $219.9M |
| 净利润 | $38.3M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 13.5% | 0.2% |
| 净利率 | 9.0% | -1.0% |
| 营收同比 | 7.9% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $0.37 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACIWOFIX
| Q1 26 | $425.7M | — | ||
| Q4 25 | $481.6M | $219.9M | ||
| Q3 25 | $482.4M | $205.6M | ||
| Q2 25 | $401.3M | $203.1M | ||
| Q1 25 | $394.6M | $193.6M | ||
| Q4 24 | $453.0M | $215.7M | ||
| Q3 24 | $451.8M | $196.6M | ||
| Q2 24 | $373.5M | $198.6M |
净利润ACIWOFIX
| Q1 26 | $38.3M | — | ||
| Q4 25 | $64.3M | $-2.2M | ||
| Q3 25 | $91.3M | $-22.8M | ||
| Q2 25 | $12.2M | $-14.1M | ||
| Q1 25 | $58.9M | $-53.1M | ||
| Q4 24 | $98.6M | $-29.1M | ||
| Q3 24 | $81.4M | $-27.4M | ||
| Q2 24 | $30.9M | $-33.4M |
毛利率ACIWOFIX
| Q1 26 | — | — | ||
| Q4 25 | 53.0% | 71.1% | ||
| Q3 25 | 53.7% | 72.2% | ||
| Q2 25 | 41.5% | 68.7% | ||
| Q1 25 | 45.9% | 62.8% | ||
| Q4 24 | 55.8% | 69.0% | ||
| Q3 24 | 56.3% | 68.7% | ||
| Q2 24 | 45.6% | 67.8% |
营业利润率ACIWOFIX
| Q1 26 | 13.5% | — | ||
| Q4 25 | 22.6% | 0.2% | ||
| Q3 25 | 26.5% | -8.3% | ||
| Q2 25 | 8.7% | -7.9% | ||
| Q1 25 | 14.8% | -25.2% | ||
| Q4 24 | 27.0% | -5.3% | ||
| Q3 24 | 27.1% | -9.6% | ||
| Q2 24 | 14.4% | -12.5% |
净利率ACIWOFIX
| Q1 26 | 9.0% | — | ||
| Q4 25 | 13.4% | -1.0% | ||
| Q3 25 | 18.9% | -11.1% | ||
| Q2 25 | 3.0% | -6.9% | ||
| Q1 25 | 14.9% | -27.4% | ||
| Q4 24 | 21.8% | -13.5% | ||
| Q3 24 | 18.0% | -13.9% | ||
| Q2 24 | 8.3% | -16.8% |
每股收益（稀释后）ACIWOFIX
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.61 | $-0.05 | ||
| Q3 25 | $0.88 | $-0.57 | ||
| Q2 25 | $0.12 | $-0.36 | ||
| Q1 25 | $0.55 | $-1.35 | ||
| Q4 24 | $0.92 | $-0.76 | ||
| Q3 24 | $0.77 | $-0.71 | ||
| Q2 24 | $0.29 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $161.8M | $82.0M |
| 总债务越低越好 | $807.4M | — |
| 股东权益账面价值 | $1.5B | $450.0M |
| 总资产 | $3.1B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.54× | — |
8季度趋势，按日历期对齐
现金及短期投资ACIWOFIX
| Q1 26 | $161.8M | — | ||
| Q4 25 | $196.5M | $82.0M | ||
| Q3 25 | $199.3M | $62.9M | ||
| Q2 25 | $189.7M | $65.6M | ||
| Q1 25 | $230.1M | $58.0M | ||
| Q4 24 | $216.4M | $83.2M | ||
| Q3 24 | $177.9M | $30.1M | ||
| Q2 24 | $157.0M | $26.4M |
总债务ACIWOFIX
| Q1 26 | $807.4M | — | ||
| Q4 25 | $817.6M | — | ||
| Q3 25 | $867.8M | $157.2M | ||
| Q2 25 | $898.0M | $157.0M | ||
| Q1 25 | $845.9M | $156.9M | ||
| Q4 24 | $924.6M | $157.0M | ||
| Q3 24 | $994.3M | $118.5M | ||
| Q2 24 | $1.0B | $118.0M |
股东权益ACIWOFIX
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $450.0M | ||
| Q3 25 | $1.5B | $442.5M | ||
| Q2 25 | $1.4B | $458.3M | ||
| Q1 25 | $1.5B | $458.3M | ||
| Q4 24 | $1.4B | $503.1M | ||
| Q3 24 | $1.3B | $525.9M | ||
| Q2 24 | $1.2B | $546.0M |
总资产ACIWOFIX
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.1B | $850.6M | ||
| Q3 25 | $3.2B | $832.6M | ||
| Q2 25 | $3.1B | $837.2M | ||
| Q1 25 | $3.2B | $823.1M | ||
| Q4 24 | $3.0B | $893.3M | ||
| Q3 24 | $3.1B | $867.9M | ||
| Q2 24 | $3.4B | $882.0M |
负债/权益比ACIWOFIX
| Q1 26 | 0.54× | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.59× | 0.36× | ||
| Q2 25 | 0.64× | 0.34× | ||
| Q1 25 | 0.57× | 0.34× | ||
| Q4 24 | 0.65× | 0.31× | ||
| Q3 24 | 0.75× | 0.23× | ||
| Q2 24 | 0.82× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ACIWOFIX
| Q1 26 | — | — | ||
| Q4 25 | $121.8M | $27.7M | ||
| Q3 25 | $73.0M | $12.4M | ||
| Q2 25 | $49.8M | $11.6M | ||
| Q1 25 | $78.2M | $-18.4M | ||
| Q4 24 | $126.5M | $23.7M | ||
| Q3 24 | $54.0M | $11.7M | ||
| Q2 24 | $55.0M | $9.0M |
自由现金流ACIWOFIX
| Q1 26 | — | — | ||
| Q4 25 | $116.6M | $16.8M | ||
| Q3 25 | $69.6M | $2.5M | ||
| Q2 25 | $47.6M | $4.5M | ||
| Q1 25 | $76.1M | $-25.1M | ||
| Q4 24 | $119.5M | $15.2M | ||
| Q3 24 | $50.5M | $6.3M | ||
| Q2 24 | $53.3M | $-360.0K |
自由现金流率ACIWOFIX
| Q1 26 | — | — | ||
| Q4 25 | 24.2% | 7.6% | ||
| Q3 25 | 14.4% | 1.2% | ||
| Q2 25 | 11.9% | 2.2% | ||
| Q1 25 | 19.3% | -13.0% | ||
| Q4 24 | 26.4% | 7.0% | ||
| Q3 24 | 11.2% | 3.2% | ||
| Q2 24 | 14.3% | -0.2% |
资本支出强度ACIWOFIX
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 4.9% | ||
| Q3 25 | 0.7% | 4.8% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.5% | 3.5% | ||
| Q4 24 | 1.5% | 4.0% | ||
| Q3 24 | 0.8% | 2.7% | ||
| Q2 24 | 0.5% | 4.7% |
现金转化率ACIWOFIX
| Q1 26 | — | — | ||
| Q4 25 | 1.89× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 4.08× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | 1.28× | — | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 1.78× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACIW
| Software as a service and platform as a service | $262.0M | 62% |
| License | $88.0M | 21% |
| Maintenance | $50.9M | 12% |
| Services | $24.8M | 6% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
